IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$494M
AUM Growth
+$192M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
157
New
Increased
Reduced
Closed

Top Buys

1 +$24.3M
2 +$22.7M
3 +$20.3M
4
PTCT icon
PTC Therapeutics
PTCT
+$14.6M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$8.84M

Top Sells

1 +$18.5M
2 +$18.4M
3 +$13.9M
4
COGT icon
Cogent Biosciences
COGT
+$12.1M
5
PRAX icon
Praxis Precision Medicines
PRAX
+$12M

Sector Composition

1 Healthcare 99.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMAB icon
1
Genmab
GMAB
$17.4B
$53M 10.73%
+175,000
ABVX
2
Abivax
ABVX
$9.23B
$33.4M 6.76%
+396,098
IONS icon
3
Ionis Pharmaceuticals
IONS
$12.9B
$27.2M 5.49%
+415,163
CDTX
4
DELISTED
Cidara Therapeutics
CDTX
$26.6M 5.38%
277,704
-186,784
MAZE
5
Maze Therapeutics
MAZE
$2.24B
$19.2M 3.89%
740,825
+478,085
PTCT icon
6
PTC Therapeutics
PTCT
$5.32B
$17.2M 3.48%
+280,551
RAPT icon
7
RAPT Therapeutics
RAPT
$15.9M 3.21%
+615,000
DNTH icon
8
Dianthus Therapeutics
DNTH
$2.68B
$13.6M 2.75%
+346,001
CYTK icon
9
Cytokinetics
CYTK
$7.61B
$12.2M 2.48%
222,674
-10,790
FULC icon
10
Fulcrum Therapeutics
FULC
$556M
$11.9M 2.4%
1,289,225
+860,704
PCVX icon
11
Vaxcyte
PCVX
$8.63B
$11.2M 2.27%
311,682
+6,682
CTMX icon
12
CytomX Therapeutics
CTMX
$859M
$10.8M 2.18%
+3,372,616
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$11.6B
$10.3M 2.07%
77,800
+37,800
APLS icon
14
Apellis Pharmaceuticals
APLS
$2.54B
$10.2M 2.07%
451,902
+376,902
CGON icon
15
CG Oncology
CGON
$5.09B
$10M 2.03%
249,473
+94,473
AKRO
16
DELISTED
Akero Therapeutics
AKRO
$9.82M 1.99%
206,854
-13,146
ZURA icon
17
Zura Bio
ZURA
$663M
$9.23M 1.87%
+2,132,322
TENX icon
18
Tenax Therapeutics
TENX
$74.6M
$7.36M 1.49%
+967,600
KOD icon
19
Kodiak Sciences
KOD
$1.64B
$6.77M 1.37%
413,841
-185,693
TGTX icon
20
TG Therapeutics
TGTX
$4.63B
$6.32M 1.28%
174,959
-34,979
ACOG
21
Alpha Cognition
ACOG
$127M
$6.16M 1.25%
946,259
+28,392
CRNX icon
22
Crinetics Pharmaceuticals
CRNX
$4.05B
$5.45M 1.1%
130,902
-302,529
VRDN icon
23
Viridian Therapeutics
VRDN
$2.9B
$5.3M 1.07%
245,518
-224,431
PHVS icon
24
Pharvaris
PHVS
$1.74B
$5.24M 1.06%
+210,165
SNDX icon
25
Syndax Pharmaceuticals
SNDX
$1.88B
$5.13M 1.04%
+333,733